Darryl Martin, PhD

Dr. Martin’s interest encompasses both translational and biomedical research. His current research focuses on understanding the mechanisms involved in chemotherapeutic resistant bladder tumors as well as identifying the molecular signatures of heterogeneous prostate cancers. Dr. Martin uses patient derived tumors, primary cancer cells and cancer mouse models to develop novel therapies. He is currently funded by the Department of Defense to study tumor-homing nanoparticles for the imaging and treatment of prostate cancer.

• Project 1 attempts to understand the mechanism(s) involved in chemotherapeutic resistant bladder tumors
• Project 2 aims to identify the molecular signatures of heterogeneous prostate cancers
• Project 3 uses functionalized nanoparticles to locate and treat prostate cancer

Resistant bladder tumors; Heterogeneous prostate cancers; Tumor-homing nanoparticles